Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
US10744227B2 · kind B2 · utility
0Cited by
10References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2019 |
| Grant date | Aug 18, 2020 |
| Priority date | — |
| Expiry date | May 1, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/34
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Hydrogels comprising a macromolecular matrix and water may be used to augment soft tissue of a human being, promote or support cell or tissue viability or proliferation, create space in tissue, and for other purposes. A macromolecular matrix may comprise a hyaluronic acid component crosslinked to a silk fibroin component.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.